Mechanistic Modulation of Lipopolysaccharide-Induced Hepatic Injury by Chitosan-Coated Selenium Nanoparticles: Targeting the STEAP-3/TLR-4 and IL-17/TRAF-6/HSP-90 Axes
<b>Background/Objectives</b>: The aim of the current study was to investigate the mechanistic hepatoprotective efficacy of selenium (SE) and chitosan-coated selenium nanoparticles (CS-SENPs) using a rat model induced by lipopolysaccharide (LPS). <b>Methods</b>: CS-SENP was prepared and characterized for particle size, polydispersity index (PDI), zeta potential, transmission electron microscope (TEM), and Fourier transform infrared spectroscopy (FTIR). Male albino rats (<i>n</i> = 40) were divided into four groups: control, LPS, SE, and CS-SENP. SE and CS-SENPs (5 mg/kg orally for 14 days) were given before LPS injection. Tissue architecture was assessed using histopathological analysis. HSP-47 and STEAP-3 protein expression levels were measured using ELISA, and oxidative stress markers were quantitatively evaluated. The expression of HO-1, TLR-4, STAT-3, TRAF-6, and IL-17A was measured using immunohistochemical analysis. Furthermore, HSP-90 expression was evaluated by immunofluorescence labeling. <b>Results</b>: CS-SENP characterization revealed uniform (PDI = 0.125 ± 0.04) nanoparticle size (108.54 ± 2.24 nm), with high zeta potential (+63.92 ± 6.287 mV), attributed to the CS layer, which was confirmed by FTIR and TEM as an electron-lucent halo enveloping the individual SENP cores. CS-SENPs significantly reduced lipid peroxidation (MDA) and restored glutathione (GSH) more effectively than SE. CS-SENPs improved redox (upregulated HO-1) and iron balance (downregulated STEAP-3), and also increased the anti-inflammatory effect (suppressed TLR-4, IL-17A, TRAF-6, and STAT-3). CS-SENPs showed superior antifibrotic efficacy (suppresses stress proteins, HSP-47 and HSP-90). Rats treated with CS-SENPs had nearly normal liver structure. <b>Conclusions</b>: The results concluded that CS-SENPs had superior and multi-targeted hepatoprotection against LPS-induced liver damage.
Authors
- Eman Hamza (ORCID: https://orcid.org/0000-0003-0064-7835)
- Amr M. Yehia (ORCID: https://orcid.org/0000-0002-5428-4286)
- Eman Ali Elkordy (ORCID: https://orcid.org/0000-0001-6533-2645)
- Ahmed S.G. Srag El-Din
- Eslam E. Abd El Fattah
- Asmaa Ramadan
Institutions
- Imam Mohammad ibn Saud Islamic University (SA)
- University of South Florida (US)
- City of Hope (US)
- Beckman Research Institute
- Delta University for Science and Technology (EG)
Publication Details
- Journal
- Pharmaceutics
- Published
- 2026-03-20
- DOI
- https://doi.org/10.3390/pharmaceutics18030388
- Primary Topic
- Selenium in Biological Systems
- Type
- article
- Field-Weighted Citation Impact
- 0.00